IGC Form 8-K Vote Prop 3-4 Adjourned Dec 15Ã¢â‚¬â„¢17 Ã¢â‚¬â€œ Nov 22Ã¢â‚¬â„¢17 - IGC Pharma, INC.

Skip to content

Home
Stock Info
Press Releases
SEC Filings
- Proxy Materials
CEO Update
Company

Home
Stock Info
Press Releases
SEC Filings
- Proxy Materials
CEO Update
Company

Search

SEC

Filings

ALL
2024
2023
2022
2021
2020
2019
Sec.gov

ALL
2024
2023
2022
2021
2020
2019
Sec.gov

IGC8-KVoteProp3-4AdjournedDec1517-Nov2217 Download

Subscribe to Newsletter

Subscribe to get our latest content by email.

Potomac, MD, USA
info@igcpharma.com
+1 301-983-0998

COMPANY

CEO Update
Deck
Board/Executives
Governance
ESG
Privacy Policy

FINANCIALS

SEC Filings
Proxy Materials
Press Releases

TRADING & DATA

NYSE: IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Tradegate Exchange

IGC Pharma, INC. © 2025

X-twitter Facebook-f Linkedin